🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.300
-0.080 (-2.37%)
Nov 18, 2026, 10:41 AM EST - Market open

Aclaris Therapeutics Revenue

Aclaris Therapeutics had revenue of $1.48M in the quarter ending September 30, 2026, a decrease of -55.11%. This brings the company's total for the last twelve months to $6.40M, down -59.34% year-over-year. In the year 2025, Aclaris Therapeutics had annual revenue of $7.83M, down -58.19%. That makes Aclaris Therapeutics the 39,160th largest company in the world by revenue and 5,168th in the United States.

Revenue (ttm)
$6.40M
Revenue Growth
-59.34%
P/S Ratio
83.75
Revenue / Employee
$87,685
Employees
73
Market Cap
523.42M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.83M-10.89M-58.19%
Dec 31, 202418.72M-12.53M-40.09%
Dec 31, 202331.25M1.50M5.03%
Dec 31, 202229.75M22.99M340.05%
Dec 31, 20216.76M279.00K4.30%
Dec 31, 20206.48M2.26M53.35%
Dec 31, 20194.23M-1.92M-31.28%
Dec 31, 20186.15M4.47M265.48%
Dec 31, 20171.68M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---